Company Quick10K Filing
Quick10K
Sterling Consolidated
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.09 47 $4
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-04-12 Accountant, Exhibits
8-K 2019-01-17 Enter Agreement, Regulation FD, Exhibits
8-K 2019-01-03 Enter Agreement, Regulation FD, Exhibits
8-K 2018-12-26 Enter Agreement, Regulation FD, Exhibits
8-K 2018-10-12 Regulation FD, Exhibits
8-K 2018-09-17 Enter Agreement, Regulation FD, Exhibits
8-K 2018-02-14 Regulation FD, Exhibits
8-K 2017-01-29 Other Events, Exhibits

Sterling Consolidated Financials

-

STCC Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comparables ($'000 Annual) Ticker Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Innovus Pharmaceuticals INNV 3,584 10,837 10,791 12,211 8,077 -8,358 -6,105 5,144
Pressure Biosciences PBIO 6,122 2,240 10,423 2,237 863 -10,008 -6,440 6,004
Biorestorative Therapies BRTX 4,552 2,432 11,375 86 0 -14,536 -14,312 3,470
Green Envirotech Holdings GETH 0 18 6,627 0 0 -3,312 -3,312 -13
All American Sportpark AASP 3,961 7 288 0 0 -90 -90 3,961
ROI Land Investments ROII 25,790 42,491 0 0 -16,488 -14,985 1,401
Janel JANL 7,836 50,911 35,884 68,996 20,250 519 922 11,979
Network Cn NWCN 877 112 12,320 0 0 -896 -323 5,869
Gilla GLLA 12,944 4,303 12,570 4,388 2,873 -5,761 -4,419 13,882
American Church Mortgage ACMC 3,607 39,356 28,807 0 0 -26 1,891 3,607
Sterling Consolidated STCC 4,728 7,036 5,715 7,564 2,328 53 347 4,695
American Bio Medica ABMC 3,580 2,165 2,584 3,643 1,091 -911 -556 4,972
Graniteshares Platinum Trust PLTM 3,632 3,656 1 0 0 -131 -131 3,632
Sangui Biotech International SGBI 1,993 51 529 75 75 -243 -254 1,974
Accelerize ACLZ 7,974 5,234 557 0 9,112 5,008 5,976 6,673
Mr. Amazing Loans MRAL 3,962 3,161 101 1,215 0 -1,247 -1,242 3,621
1847 Holdings EFSH 19,469 22,957 18,779 6,164 -2,004 186 3,504
Reflect Scientific RSCF 3,164 632 138 1,403 946 -154 -154 2,959
Mount Tam Biotechnologies MNTM 2,228 59 2,661 0 0 -1,230 -1,149 2,187
United States 12 Month Natural Gas Fund UNL 4,131 33 -78 0 -126 -126 -4,628

Balance Sheet ($'000)2013-06-302013-09-302013-12-312014-03-312014-06-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash10877544317971311852331862217742214372530643290
Accounts Receivable8431,0348021,0941,1889799758257237337947225745567527908027579368531,0139431,725
Inventory2,3762,3722,7262,4092,6512,8892,7952,7762,7212,7972,8072,7952,8272,7232,6442,8282,9312,5052,3132,2042,1372,5603,184
PP&E2,6292,6022,5952,6512,6833,6222,5482,5972,4893,7001,8751,8181,7853,1581,9071,8611,8463,1281,6981,6681,6403,0521,601
Assets6,0076,1386,8156,5636,9906,8826,7876,7546,3766,3925,8035,8195,6095,4965,6055,8115,8605,7085,6585,4395,5235,5877,036
Accounts Payable
Long-Term Debt
Liabilities4,7284,8055,6035,2695,5305,4935,4405,4295,2995,5375,0235,0384,8424,7274,7474,9674,9334,9534,9054,7084,7594,7875,715
Stockholders' Equity1,2791,3331,2121,2951,4601,3881,3471,3251,0778547817817677698588449277557537327648011,320
Income Statement ($'000)2013-06-302013-09-302013-12-312014-03-312014-06-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Revenue1,5011,6031,4181,7392,0201,7381,6861,5061,4691,4821,5561,3841,3161,7831,5701,5871,5131,7971,5211,7142,0782,250
Cost of Revenue1,0161,2106561,1341,2501,2631,2001,2681,4391,1021,1159201,0391,2201,1851,2171,8061,3301,2691,2021,2661,611
Gross Profit48539376260584647548623830380441464277563384370-293467365512812639
R&D11200030
SG&A62634188944764950352549920432403458175393374427668448397425494539
Tax-6321057471-9-74-800-971590011101419
Net Income-1075-10686123-48-22-248-198-741-142898883-689-100-21332120
Cash Flow ($'000)2013-06-302013-09-302013-12-312014-03-312014-06-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash Operating-55-26326972-71-202
Cash Investing-52200000-280
Cash Financing7729-44-64-3839540